Despite the importance of blood platelets in health and disease, the mechanisms regulating their formation within megakaryocytes are unknown. We generated mice lacking the hematopoietic subunit (p45) of the heterodimeric erythroid transcription factor NF-E2. Unexpectedly, NF-E2 -I-mice lack circulating platelets and die of hemorrhage; their megakaryocytes show no cytoplasmic platelet formation. Though platelets are absent, serum levels of the growth factor thrombopoietin/MGDF are not elevated above controls. Nonetheless, NF-E2 -/-megakaryocytes proliferate in vivo in response to thrombopoietin administration. Thus, as an essential factor for megakaryocyte maturation and platelet production, NF-E2 must regulate critical target genes independent of the action of thrombopoietin. These findings provide insight into the genetic analysis of megakaryocyte maturation and thrombopoiesis.
Introduction
Circulating blood platelets constitute a primary defense against bleeding and are essential for survival (Lind, 1995) . Abnormalities in platelet number or function contribute to various hemorrhagic and thrombotic disorders, and the events surrounding platelet activation have been studied extensively. In contrast, megakaryocytes, the precursors of platelets, have been less well characterized, in part because they constitute less than 1% of the cellular elements in normal bone marrow.
Like other blood cells, megakaryocytes differentiate from pluripotent hematopoietic stem cells in a process that imparts a unique phenotype to each lineage, including the expression of characteristic gene products and the response to specific growth factors. The distinctive patterns of gene expression of individual lineages are established largely through the aegis of cell-specific transcription factors, several of which have been implicated in the determination of hematopoietic cell fate and maturation. For example, the nuclear proteins GATA-1 (Pevny et al., 1991) , Myb (Mucenski et al., 1991) , Rbtn2 (Warren et al., 1994) , TaI-1/SCL (Shivdasani et al., 1995) , Ikaros (Georgopoulos et al., 1994) , E2A (Bain et al., 1994; Zhuang et al., 1994) , Pax5/BSAP (Urbdnek et al., 1994) , and PU.1 (Scott et al., 1994) are essential for normal erythroid, lymphoid, or myeloid differentiation. The transcriptional basis of megakaryocyte development remains undefined.
The megakaryocytic and erythroid lineages are closely related in ontogeny: both cell types are derived from a common committed progenitor (Suda et al., 1983; Ogawa, 1989) . Moreover, the proliferation and maturation of megakaryocyte and erythroid precursors are regulated by structurally related growth factors, thrombopoietin (also called megakaryocyte growth and development factor, or MGDF) and erythropoietin, respectively (reviewed by Metcalf, 1994) . Further, important transcription factors, including GATA-1 (Martin et al., 1990; Romeo et al., 1990) , NF-E2 (Andrews et al., 1993a) , and TaI-1/SCL (Mouthon et al., 1993) , are coexpressed within the two lineages, raising the possibility of common programs or mechanisms of gene activation.
Megakaryocyte maturation and platelet production are complex processes. Early in their development, megakaryoblasts undergo successive rounds of DNA replication without cell division (endomitosis), resulting in polyploidy (Odell and Jackson, 1968) . Cytoplasmic maturation is characterized by the formation of granules containing procoagulant substances and the development of an extensive system of demarcation membranes, which delimit platelet territories, or platelet fields. Individual platelets are released upon fragmentation of the megakaryocyte cytoplasm (Zucker-Franklin and Petursson, 1984) or after formation of cytoplasmic processes called proplatelets (Choi et al., 1995) .
The recent discovery that thrombopoietin/MGDF acts through the megakaryocyte-specific receptor c-Mpl (Souyri et al., 1990) to promote proliferation and maturation of megakaryocyte precursors has provided impetus for the study of megakaryocyte biology (Bartley et al., 1994; de Sauvage et al., 1994; Kaushansky et al., 1994; Lok et al., 1994; Wendling et al., 1994) . However, the mechanisms responsible for the activities attributed to this factor remain to be explored. Notably, although mpl-knockout mice are thrombocytopenic, they do not suffer a bleeding diathesis . Hence, additional growth factors act in vivo to promote megakaryocyte development and platelet production.
We have studied the transcription factor NF-E2, a protein first shown to bind tandem AP-l-like motifs within DNase I hypersensitive site 2 of the locus control region (LCR) of the human 13-globin gene cluster (Mignotte et al., 1989; Ney et al., 1990a; Talbot et al., 1990) . As the sequences to which it binds are critical for LCR activity in transgenic mouse and cell transfection assays (Ney et al., 1990b; Talbot and Grosveld, 1991; Caterina et al., 1994) , a role for N F-E2 in eryth roid cell globin gene expression has been inferred. NF-E2 is an obligate heterodimer of hematopoietic-restricted 45 kDa (p45) and widely expressed 18 kDa (p18) subunits, which belong to the CNC and Maf subfamilies, respectively, of the basic regionleucine zipper (bZIP) superfamily of nuclear proteins (Andrews et al., 1993a (Andrews et al., , 1993b Igarashi et al., 1994) . The p45 subunit is coexpressed with GATA-1 in hematopoietic cells of erythroid, megakaryocyte, and mast cell lineages (Andrews et al., 1993a) . While NF-E2 has been implicated as the major enhancer for globin gene expression in maturing erythroid cells, its function elsewhere is unknown.
To define the in vivo roles of NF-E2, we used gene targeting in embryonic stem (ES) cells (Capecchi, 1989) to generate mice lacking the p45 subunit. Although we anticipated that these mice would die early in development because of inadequate hemoglobin production, this was not the case; erythropoiesis was relatively normal. Instead, mice lacking p45 NF-E2 exhibited high mortality from hemorrhage secondary to the absence of circulating platelets (absolute thrombocytopenia). Megakaryocytes were present, and ultrastructural studies revealed the failure of platelet formation within their cytoplasm. Despite this block in cellular maturation, the proliferative response of mutant megakaryocytes to thrombopoietin was intact.
Our findings indicate that NF-E2 regulates the expression of one or more target genes required for the completion of megakaryocyte maturation and platelet production. Together with emerging studies on thrombopoietin-mediated signaling through Mpl, these findings provide a framework for molecular genetic approaches to the study of platelet production.
Results

Targeted Disruption of the Murine p45 NF-E2 Gene
The murine p45 NF-E2 gene contains three exons, the last of which encodes the bZIP region required for DNA binding and protein dimerization (Andrews et al., 1993a) . To inactivate the gene, a targeting construct was assembled in which a n e o R cassette was inserted in exon 3, immediately upstream of sequences encoding the basic domain ( Figure 1A ). Any product translated from the disrupted allele would thus be unable to bind DNA or form heterodimers and consequently would be inactive.
Following electroporation of the targeting construct, ES cell clones were selected in G418 and assayed by Southern blot analysis ( Figure 1B) , which revealed homologous recombination in -4 0 % of G418-resistant clones. Two independent clones contributed to the germline of chimeric mice, whose heterozygous (p45 NF-E2 +1-) offspring were interbred to generate homozygotes. stocks were maintained on either a mixed 129/Sv-C57BL/6 or inbred 129/Sv background; no difference was observed between these lines or between mice derived from the two ES cell clones. p45 NF-E2 ÷j-mice appeared normal up to 1 year of age, and interbreeding yielded p45 NF-E2 + mice at the expected Mendelian frequency of 1 in 4 ( Figure 1C ). Absence of intact p45 NF-E2 mRNA and protein in fetal liver samples of homozygotes was demonstrated by Northern blot and immunoblot analyses, respectively (Figures 2A and 2C) . Although a readthrough transcript containing the inserted n e o phosphotransferase gene sequences was detected in fetal liver RNAs of (+/-) as well as (-/-) mice (Figure 2A ), DNA sequencing of the targeting construct confirmed that the insertion provided multiple in-frame stop codons (data not shown). Thus, the targeting produced a null mutation of the p45 NF-E2 gene.
Adventitious integration of Friend virus DNA in CB3 erythroleukemia cells inactivates the p45 NF-E2 gene as well as the adjacent gene that encodes the heterogeneous nuclear RNA-binding protein A1 (hnRNPA1) (Ben-David et al., 1992; Lu et al., 1994) . Although this is likely due to a distance effect exerted by viral long terminal repeats, we excluded the possibility that disruption of the p45 NF-E2 gene in ES cells also inactivated this linked gene. hnRNPA1 mRNA was present at normal levels in p45 NF-E2 -/-fetal liver ( Figure 2B ). The phenotype we describe below for homozygous mice thus represents the specific consequences of absence of p45 NF-E2.
Hemorrhage and Perinatal Mortality in p45 NF-E2 + Mice p45 NF-E2 + mice were distinguished after birth by pallor and internal hemorrhage occurring primarily into the peritoneal cavity and the wall of the urinary bladder ( Figure  3 ), presumably as a complication of birth-related trauma. Although the frequency of homozygotes at birth was as expected ( -25%), less than 10% of the liveborn homozygotes survived to adulthood, and surviving neonates were smaller than littermates ( Figure 3A ), presumably as a result of sustained hemorrhage during a period of rapid growth. With the exception of splenomegaly, which was present at birth and persisted thereafter, the appearance and histology of other organs were normal. However, hemorrhage was frequently observed in the gastrointestinal tract, brain, testes, pericardium, and mouth. Significant bleeding was not detected in embryos delivered by cesarean section. Thus, the majority of p45 N F-E2 -~-mice die in the neonatal period as a consequence of hemorrhage. Although anemia was observed intermittently in surviving adult homozygotes, these mice appeared otherwise normal. Both sexes were fertile.
Absence of Platelets in p45 NF-E2 -~-Mice
p45 NF-E2 -/-mice succumb to bleeding due to the absence of circulating platelets (absolute thrombocytopenia). In contrast with wild-type and heterozygous littermates, whose platelet counts were between 5 x 10s/ Id (young mice) and 0.8 to 1.4 x 10e/p.I (adults), no platelets could be identified in blood smears ( Figure 4A ), or by automated analysis of blood ( Figure 4B ), from p45 NF-E2 + mice. Thrombocytopenia was evident during embryonic development and persisted throughout life. Transfer of serum from p45 NF-E2 + mice failed to lower platelet counts in normal recipients either 1-2 hr after intravenous injection or up to 1 week following daily intraperitoneal injections (data not shown). Thus, thrombocytopenia does not result from platelet destruction by a soluble factor but reflects a primary failure in platelet formation. In the spleen and bone marrow of mutant mice, megakaryocytes were present in slight excess (2-to 4-fold) relative to wildtype or heterozygous littermates ( Figure 4C ). The majority of these cells appeared larger than control megakaryocytes and exhibited hyperlobulation of the nucleus and striking emperipolesis (nonphagocytic inclusion of other blood cells within the cytoplasm [Breton-Gorius, 1981] ). Taken together, these findings indicate that thrombocytopenia in p45 NF-E2 + mice occurs despite the presence of megakaryocytes and point to a maturation defect as the cause for absence of circulating platelets.
Hematological Analysis of p45 NF-E2 -I-Mice
The numbers and morphology of granulocytes and lymphocytes in blood and bone marrow were normal in p45 NF-E2 -/-mice (data not shown). In contrast, mild, but consistent, changes were seen in the red blood cells. As will be described elsewhere, these included reduced hemoglobin concentration and microcytosis that cannot be explained fully by either blood loss or iron deficiency (R. A. S. et al., unpublished data). Hence, the absence of NF-E2 affects erythrocytes only mildly, but leads to profound consequences for megakaryocytes, a second lineage in which it is normally expressed.
Absence of p45 NF-E2 Results in a Late Block in Megakaryocyte Maturation
Normal megakaryocyte development initiates with the pro-A B liferation of precursor cells. Later, these cells undergo endomitosis, followed by cytoplasmic maturation and organization, which culminate in platelet release (Zucker-Franklin, 1989) . To identify the stage at which NF-E2 is required, we examined megakaryocyte-specific mRNA levels by reverse transcription-polymerase chain reaction (RT-PCR). mRNAs encoding platelet factor 4 (PF4) and glycoprotein lib (GPIIb), early markers of the megakaryocyte lineage (Deuel et al., 1977; Beckstead et al., 1986) , were expressed at similar levels in fetal livers of p45 NF-E2 -~-and control mice ( Figure 5A ). Other early markers of mouse megakaryocytes, acetylcholinesterase activity (Jackson, 1973) , and surface expression of the epitope defined by the 4A5 monoclonal antibody (Burstein et al., 1992) , were also detected in mutant megakaryocytes (data not shown). Thus, megakaryocyte maturation in p45 NF-E2 -~-mice is affected after the stage at which these markers are expressed, and NF-E2 is not essential for their expression.
To determine whether endomitosis was affected by the absence of NF-E2, we performed DNA ploidy analysis on bone marrow cells. The modal ploidy class of p45 NF-E2 -~-megakaryocytes was 32N, compared with 16N in controls ( Figure 5B ), indicating that endomitosis is not impaired in the mutant cells. Together, these experiments demon- strate that early phases of megakaryocyte development proceed normally in the absence of NF-E2.
Intrinsic Megakaryocytic Abnormalities Revealed by Electron Microscopy
To characterize the maturation defect further, we performed electron microscopy of bone marrow cells, In contrast with control megakaryocytes ( Figures 6A and 6B ), which exhibited well-formed platelet territories or fields (Zucker-Franklin, 1989) , p45 NF-E2 -~-megakaryocytes were larger and exhibited a paucity of granules ( Figure  6C ). In addition, cytoplasmic territories, the recognized precursors of platelets, were not delimited by the demarcation membranes; instead, the latter lacked appropriate organization and appeared to be in disarray ( Figure 6D ). Nuclei of mutant megakaryocytes were hyperlobulated, with a peripheral heterochromatin distribution reminiscent of blast cells, while some profiles presented numerous pinched-off nuclear fragments (data not shown). Similar abnormalities were noted in splenic megakaryocytes. In summary, ultrastructural analysis of p45 NF-E2 -~- megakaryocytes revealed a striking deficit in the number of granules and absence of platelet territories. Thus, thrombocytopenia results from a primary failure of platelet development rather than from a defect merely restricted to platelet release.
The Defect in Maturation of p45 NF-E2 -/-Megakaryocytes Is Independent of the Action of Thrombopoietin
Thrombopoietin/MGDF is believed to be the major physiological regulator of megakaryocyte proliferation and platelet production, as serum levels correlate inversely with platelet counts in mice and rabbits (Kuter and Rosenberg, 1994; Wendling et al., 1994) . This implies positive and negative feedback regulation of thrombopoietin levels by platelet mass and predicts a greatly elevated level in p45 NF-E2 -j-mice. To our surprise, serum thrombopoietin, determined with a sensitive in vitro bioassay that measures proliferation of a factor-dependent 32D cell line expressing mpl (Bartley et al., 1994) , was not above the baseline level of littermate controls (data not shown). This unexpected result was verified independently by A. L. Gurney and F. J. de Sauvage (personal communication) with a similar assay , and the possibility of inhibitors in the mutant serum accounting for the result was excluded in mixing experiments (data not shown). This finding raised the possibility that the maturation defect of p45 NF-E2 -/-megakaryocytes reflects inadequate thrombopoietin production or a failure to respond to the growth factor and led us to assess expression of the relevant genes in the mutant mice. mRNA transcripts for both mpl and thrombopoietin were present at comparable levels in fetal liver RNA samples from mutant and control mice ( Figure 7A) . Thus, the expression of neither thrombopoietin nor its receptor is dependent on NF-E2. To determine whether thrombocytopenia in p45 NF-E2 -/-mice results from the inability to respond to th rombopoietin signaling in vivo, recombinant human thrombopoietin was administered to mutant and control mice. Platelets remained undetectable in mice lacking p45 NF-E2, but increased appropriately in controls ( Figure 7B) ; nonetheless, the numbers of megakaryocytes in hematopoietic tissues were dramatically increased in both sets of mice ( Figure 7C ). These results demonstrate that the proliferative response of megakaryocyte precursors to thrombopoietin is intact in animals lacking p45 NF-E2 and indicate that the deficit leading to impaired megakaryocyte maturation is independent, of the actions of this growth factor.
Discussion
We have shown that absence of the hematopoieticspecific subunit (p45) of the bZlP transcription factor NF-E2 results in a complete, and apparently late, block in megakaryocyte maturation, such that circulating platelets are undetectable in vivo. Though dispensable for erythroid cell development, NF-E2 is thus obligatory for megakaryocyte maturation and thrombopoiesis. These unexpected findings have important implications for megakaryocyte and platelet biology.
NF-E2 in Megakaryocyte Differentiation and Gene Expression
Our results demonstrate that lineage commitment and initial phases of megakaryocyte development occur independent of the action of NF-E2. Proliferation in response to thrombopoietin, expression of selected lineage-specific markers (PF4, GPIIb, 4A5, and acetylcholinesterase), and endomitosis are unaffected in p45 NF-E2 -/-mice. Thus, in contrast with situations in which loss of transcription factors leads to ablation of one or more blood cell lineages at the level of an early precursor (see Orkin, 1995) , loss of p45 NF-E2 interferes with megakaryocytic maturation at an advanced stage. The principal defect in p45 NF-E2 -/-megakaryocytes relates to cellular maturation: the ultrastructure reveals markedly reduced numbers of granules and failure to form platelet fields. While i t~ is formally possible that these effects result from absence of NF-E2 in a cell type other than the megakaryocyte (for example, a stromal or other hematopoietic cell), the normal expression pattern of the p45 subunit, together with the discrete intracellular defects observed within the mutant megakaryocytes, suggests that the phenotype is cell autonomous.
Although late stages of nuclear maturation may overlap with early cytoplasmic events related to platelet formation, it is believed that endomitosis largely precedes the latter during megakaryocyte development (Odell and Jackson, 1968; Paulus, 1970) . Our observation of increased DNA ploidy in p46 NF-E2 -~-megakaryocytes is consistent with this model. Further, while effects of other cytokines cannot be excluded, the increased numbers, cell size, and DNA ploidy seen in the mutant megakaryocytes suggest an ongoing response to endogenous thrombopoietin. The significance of other morphological changes, including emperipolesis and nuclear hyperlobulation, is unclear; these may be caused directly by loss of NF-E2 function or related to secondary effects of thrombocytopenia or cell senescence.
Our findings implicate NF-E2-regulated target genes as critical to megakaryocyte maturation and platelet formation. Two nonmutually exclusive possibilities may be considered. On the one hand, NF-E2 loss might influence a single target gene whose absence interrupts a cascade of essential events. For example, loss of a protein required for the formation of platelet granules might perturb subsequent cellular maturation. Alternatively, NF-E2 might orchestrate the expression of sets of genes that characterize the mature, platelet-producing megakaryocyte. Identification of genes controlled by NF-E2 in megakaryocytes will be necessary to address these possibilities.
To date, the cis elements directing megakaryocytespecific expression have been defined for very few genes; in each instance, motifs recognized by proteins of the GATA and Ets families have been identified (Romeo et al., 1990; Ravid et al., 1992; Lemarchandel et al., 1993; Block et al., 1994) . Functionally relevant NF-E2-binding sites have yet to be demonstrated in the promoter of any megakaryocyte-expressed gene. Use of subtractive hybridization or differential screening methods with RNA derived from normal and p45 NF-E2 -~-megakaryocytes should facilitate the search for NF-E2-regulated genes governing megakaryocyte maturation and thrombopoiesis.
p45 NF-E2 -/-Mice: A Model for Absolute Thrombocytopenia
Although thrombocytopenia has been described in mice with the scat mutation (Peters et al., 1990) , in knockouts of the platelet-derived growth factor B (PDGF B) (Leveen et al., 1994) , PDGF receptor (Soriano, 1994) , and c-mpl genes, and in rare platelet storage pool diseases (Swank et al., 1993) , the causes, magnitude of thrombocytopenia, and clinical syndrome of each differ substantially from our observations in p45 NF-E2 -~-mice.
Similarly, mice harboring a PF4 promoter-driven SV40 T transgene exhibit variable th rombocytopenia and develop leukemia, but do not bleed excessively (Robinson et al., 1994) . Further, in three instances in which targeted disruption of hematopoietic-specific transcription factor genes (Myb, PU.1, and GATA-1) results in severe erythroid or myelolymphoid defects in utero, megakaryocyte development is spared (Mucenski et al., 1991; Scott et al., 1994; Pevny et al., 1995) . In contrast, mice lacking p45 NF-E2 have a complete and sustained absence of circulating platelets. As such, they constitute a unique model in which to dissect molecular aspects of platetet development and regulation. For example, we have shown that serum levels of thrombopoietin may not depend exclusively on the absolute numbers of circulating platelets, as previously thought. Also, NF-E2 -~-mice may be useful in blastocyst complementation studies (Chen et al., 1993) to test the requirement for other genes in platelet development.
There is no clear correspondence between the megakaryocyte maturation abnormalities seen in p45 NF-E2 -~-mice and known human platelet disorders. In humans, congenital thrombocytopenia is rare, and absolute thrombocytopenia is probably lethal. Indeed, it is surprising that 5%-10% of p45 NF-E2 -/-mice survive into adulthood. The hemostatic mechanisms operating in these survivors are presently unknown, but may include rare, circulating megakaryocyte debris.
NF-E2 Function in Megakaryocytes and Erythroid Cells
The relatively mild erythrocyte abnormalities in p45 NF-E2 -~-mice are surprising in light of prior studies implicating NF-E2 as a major enhancer protein for globin gene transcription (Ney et al., 1990b; Talbot and Grosveld, 1991; R. A. S. et al., unpublished data) . Nevertheless, the presence of abnormalities in two of the hematopoietic lineages in which NF-E2 is normally expressed indicates that the overlapping pattern of expression reflects functional requirements rather than a vestige of the shared lineage. We presume that the presence of compensating proteins in maturing erythrocytes accounts for their mild deficit and infer that similar proteins are either not expressed or not functional in megakaryocytes. Although the differing effect on erythroid and megakaryocytic maturation raises the possibility that the p45 subunit of NF-E2 forms heterodimers with distinct partners in each cell type, the similar appearance of gel-shift complexes formed on an NF-E2-binding site with nuclear extracts of erythroid and megakaryocytic cell lines (Romeo et al., 1990) suggests that this is not the case. As our findings argue that NF-E2 fulfills specific roles in megakaryocyte development, we speculate that the p45 NF-E2 protein evolved initially to function within a common progenitor and subsequently developed distinct functions within the daughter lineages.
NF-E2 and Thrombopoietin
Animal models have supported the notion that the platelet count serves as the major physiological signal for thrombopoietin production through positive as well as negative feedback (Kuter and Rosenberg, 1994; Wendling et al., 1994) . While this may yet be the case under physiological conditions, the normal serum thrombopoietin level seen in the face of profound thrombocytopenia in p45 NF-E2 -~-mice calls for an explanation. Our data are consistent with the hypothesis that the number of megakaryocytes present in hematopoietic tissues is an important physiological signal in the regulation of thrombopoietin production, as implied by previous experiments in rats and humans (Mazur et al., 1981; Miura et al., 1988) . Alternately, other aspects of platelet function, which are deficient in p45 NF-E2 -~-mice, may be primary regulators of thrombopoietin production. Blood levels of the related growth factor erythropoietin respond to a variety of signals, including hypoxia and metal ions (Goldberg et al., 1988) , and the regulation of thrombopoietin production may be similarly complex. Indeed, megakaryocyte responses to varying platelet demands have been considered to be analogous to erythroid cell changes in response to low or high red cell counts (Burstein and Breton-Gorius, 1995) .
Biochemical correlates of individual phases of megakaryocyte maturation and platelet production are poorly understood. Nevertheless, thrombopoietin appears to exert substantial physiological effects on many aspects of megakaryocyte maturation, including cell size, DNA ploidy, and platelet production (Bartley et al., 1994; Kaushansky et al., 1994) . These pleiotropic effects are likely to be mediated by genes that are activated following a thrombopoietin-mediated signaling cascade. It is possible that a subset of genes responsive to this pathway are also regulated through NF-E2, particularly late in megakaryocyte development. If so, the identification of these target genes will converge on common molecular events that are critical for platelet formation.
Future Prospects
Targeted disruption of genes encoding lineage-restricted transcription factors often results in ablation of the lineage at a very early stage (reviewed by Orkin, 1995) . Though useful in establishing factors as candidate regulators of cell fate decisions, such outcomes prohibit detailed analysis of presumptive target genes and of their roles in later stages of cell maturation. In contrast, the late developmental arrest seen in the absence of p45 NF-E2 provides a unique entry point into megakaryocyte development and thrombopoiesis. By virtue of a defined genetic defect, p45 NF-E2 -~-megakaryocytes constitute a powerful resource for the systematic analysis of development of this lineage, and the identification of NF-E2-regulated genes should aid in defining the pathway by which platelets are produced within maturing megakaryocytes.
Experimental Procedures
Targeted Disruption of the p45 NF-E2 Locus Murine p45 NF-E2 genomic sequences were isolated from a 129/Sv strain XFIXII library (Stratagene). A -12 kb fragment extending from an EcoRV site in intron 1 to an artificial Notl site 5 kb 3' to the gene was subcloned, and a PGK-neo ~ cassette was introduced at the unique Sail site of exon 3. Transfected J1 ES cells (Li et al., 1992) were cultured and selected in G418 as before (Shivdasani et al., 1995) . Genomic DNA was analyzed by Southern blotting (Figure 1B) , using a 1 kb HindllI-EcoRV fragment as a flanking probe ( Figure 1A ). Blastocyst injections and animal husbandry were performed as described (Robertson, 1987) . Male chimeras, identified by the agouti coat color, were mated with C57BL/6J (Jackson Laboratories) or 129/Sv (Taconic) females and heterozygous (p45 NF-E2 +/-) progeny identified by Southern blot analysis of tail DNA. Heterozygote crosses generated homozygous (p45 NF-E2 -j-) mutant mice on either a mixed C57-129 or inbred 129/Sv genetic background.
Histological Analysis
Following dissection, specimens were fixed overnight in 10% buffered formalin and embedded in paraffin. Sections (5-10 p.m) were stained with hematoxylin and eosin for histological examination.
Hematological Analysis
Peripheral blood cell counts were determined with a Technicon H3 instrument. Blood (50 rd) was collected into microtiter EDTA tubes (Becton-Dickinson) and diluted 1:4 in preservation buffer (10 mM NaCI, 150 mM KCI, 10 mM glucose, 1 mM MgCI2, 2.5 mM potassium phosphate [pH 7.5]). Blood smears, prepared prior to dilution, were stained with Wright-Giemsa stain.
Ultrastructural Studies
Freshly excised spleens and bone marrow obtained from 15-to 17-week-old p45 NF-E2 -j and control mice were fixed in 3% glutaraldehyde prior to routine processing for electron microscopy. Samples were postfixed in 2% osmium tetroxide, stained en boc with uranyl acetate, and dehydrated in graded ethanols prior to embedment in Polybed 812 (Polysciences, Incorporated). Embedded tissues were sectioned with an LKB Ultrotome Ill microtome, stained with uranyl acetate and lead citrate, and examined with a Siemens Elmiskop IA electron microscope.
Detection of Gene Products
Northern blot and immunoblot analyses were performed as described previously (Andrews et al., 1993a) . For RT-PCR analysis, RNA was prepared from livers dissected from E15.5 fetuses (Chomczynski and Sacchi, 1987) . First-strand cDNA synthesis and PCR reactions (94°Cx1', 60°Cxl ', 72°Cx2 ') in the presence of tracer [32P]dCTP were performed as described (Shivdasani et al., 1995) . The number of PCR cycles corresponded to the high end of the range in which a linear increase in products could be detected. Reaction products were separated on nondenaturing 4% polyacrylamide gels. No reaction products were detected using RNA samples from which reverse transcriptase had been omitted (data not shown). Equivalence of mutant and control cDNA was verified using PCR reactions for actin and HPRT (data not shown). Primer Sets PF4, 5' CTC'I-I'GACATGAGCGTCGCTGCGG 3' and 5' CI-FGATCAC-CTCCAGGCAGGTGAA 3'; GPIIb, 5' AGGCAGAGAAGACTCCGGTA 3' and 5q'ACCGAATATCCCCGGTAAC 3'; thrombopoietin, 5' CATA-CAGGGAGCCACI-ICAGT 3'and 5'AGACGCTCTG GGCCAGTGCCC 3'; c-mpl, 5' CCCACCTGGGAGAAATGTGAAGAG 3' and 5' CCGGTG-TAGGTCTGGAAGCGAGGG 3'. Acetylcholinesterase activity was detected as described (Jackson, 1973) .
Measurement of Megakaryocyte DNA Content
DNA distribution of megakaryocytes in unfractionated bone marrow was determined as previously described (Jackson et al., 1984) . Marrow was harvested from the femurs of 6-to 12-week-old mutant and control mice and washed in CATCH medium (Levine and Fedorko, 1976) . To label the megakaryocyte population, cell suspensions were incubated first with 4A5 monoclonal antibody supernatant (Burstein et al., 1992) and subsequently with fluorescein-conjugated goat anti-rat IgGF(ab')2 (Tago, Incorporated); DNA was stained with propidium iodide in hypotonic citrate. Using a FACScan flow cytofluorometer (Becton-Dickinson) and two-color flow cytometry, DNA content (2N to 64N) of all 4A5-positive cells was measured. Only cells with DNA content ~>8N were considered, since the proportions of 2N and 4N platelet-antibodystained cells in unfractionated marrow is highly dependent on selection of the green fluorescence gate. The proportion of cells in each ploidy class was determined by integrating the area under each peak.
ThrombopoietinlMGDF Studies
Serum levels were measured as described (Bartley et al., 1994) , using mpl-transfected, th rombopoietin-dependent 32D cells. For in vivo studies, purified recombinant full-length human factor (0.1 p.g/g body weight), prepared from transfected CHO cells (Amgen), was administered subcutaneously daily for 7 days prior to measurement of platelet counts or determination of megakaryocyte numbers.
